SeaStar Medical加强董事会并向商业舞台公司转型

DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) announces that three new members have joined its Board of Directors. Two new directors, Jennifer A. Baird and Bernadette N. Vincent, were elected at the Company’s 2024 Annual Meeting of Stockholders held on June 4, and John Neuman was appointed to the Board on June 5.

丹佛，2024年6月10日（环球通讯社）--SeaStar Medical Holding Corporation（纳斯达克：ICU）（SeaStar Medical）宣布三名新成员加入其董事会。在6月4日举行的2024年公司股东年会上，两名新董事詹妮弗·贝尔德（JenniferA.Baird）和伯纳黛特·文森特（BernadetteN.Vincent）当选，约翰·纽曼（JohnNeuman）于6月5日被任命为董事会成员。

Former directors Bruce Rodgers and Richard Russell did not stand for reelection at the 2024 Annual Meeting, and Andres Lobo announced his retirement from Dow Chemical, resulting in his departure from the SeaStar Medical Board. “We are delighted to add three outstanding professionals in Jennifer, Bernadette and John to our Board,” said Rick Barnett, SeaStar Medical’s Chairman.

前董事布鲁斯·罗杰斯（BruceRodgers）和理查德·罗素（RichardRussell）在2024年的年会上没有竞选连任，安德烈斯·洛博（AndresLobo）宣布从陶氏化学公司退休，从而离开了SeaStar医疗董事会。SeaStar Medical董事长里克·巴内特（RickBarnett）表示：“我们很高兴在董事会中加入詹妮弗（Jennifer）、伯纳黛特（Bernadette）和约翰（John）三位杰出的专业人士。”。

“Our new Directors bring significant leadership, financial and formidable industry experience that will be highly valuable as SeaStar Medical continues its transition to a commercial-stage company. We look forward to their contributions. On behalf of the Board, I’d like to express our appreciation for the services provided by Andres, Bruce and Richard.” Ms.

“随着SeaStar Medical继续向商业舞台公司转型，我们的新董事带来了重要的领导力、财务和强大的行业经验，这将是非常有价值的。我们期待着他们的贡献。我谨代表董事会对Andres、Bruce和Richard提供的服务表示感谢。”。

Baird serves as the Executive Chair of Culturewell, Co., an organization that delivers actionable insight for healthcare infection prevention through environmental sampling testing and germ risk assessments. She previously was CEO and Director of the medical device software company Fifth Eye Inc. and CEO and Director of the renewable energy technology company Accio Energy, Inc.

Baird担任Culturewell，Co.的执行主席，该组织通过环境采样测试和细菌风险评估为医疗保健感染预防提供可行的见解。她曾担任医疗器械软件公司Fifth Eye Inc.的首席执行官兼董事，以及可再生能源技术公司Accio energy，Inc.的首席执行官兼董事。

Prior to that, Ms. Baird co-founded and served as CEO and Director at the healthcare-based companies Accuri Cytometers, Inc. (acquired by Becton Dickinson) and Sonetics Ultrasound, Inc. She serves as a Director for the non-profit Hope Clinic and advisor for the Michigan Founders Fund. Ms. Baird hol.

在此之前，贝尔德女士共同创立并担任医疗保健公司Accuri Cytometers，Inc.（被Becton Dickinson收购）和Sonetics Ultrasound，Inc.的首席执行官和董事。她担任非营利性希望诊所的董事和密歇根创始人基金的顾问。贝尔德·霍尔女士。

网址：SeaStar Medical加强董事会并向商业舞台公司转型 http://c.mxgxt.com/news/view/1399361

相关内容

Seastar
公司商业模式大幅调整，从渠道导向转为品牌导向，品牌转型初见成效
ST曙光：公司将持续加强产品研发，加快产品转型升级
永泰能源董秘回复：公司正有序推进新能源转型规划与布局，加快构建公司发展新格局。一是通过与知名高校、科研院所和行业头部企业合作，加快公司向新能源领域转型与布局，逐步实现绿色低碳转型发展。公司子公司华元新能源已与三峡电能签署战略合作协议，双方将
李楚源时代落幕：白云山董事长突然离职，行业转型期挑战加剧
电声股份业绩会：推动业务向数字化、智能化转型
虎牙公司董事长林松涛：推动游戏服务转型，第二增长曲线继续显现
吴奇隆公司注销成谜，商业转型？资本动向引关注
董事长及多名董事涉案，昔日明星企业面临危机，这一行业加速洗牌
曹国伟表示微博平台型公司的地位更加稳固

随便看看